Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
American Journal of Respiratory and Critical Care Medicine|May 19, 2026
Gut microbiota associate with disease severity and survival in idiopathic pulmonary fibrosisJohn S Kim, Abigail Loe, Shwu-Fan Ma, et al.
American Journal of Respiratory and Critical Care Medicine|October 17, 2023
Proteomic Biomarkers of Survival in Idiopathic Pulmonary FibrosisJustin M Oldham, Yong Huang, Swaraj Bose, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association studyImre Noth, Yingze Zhang, Shwu-Fan Ma, et al.
JCI Insight|May 4, 2021
Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPFMiriam S Hohmann, David M Habiel, Milena S Espindola, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation AnalysisJanelle Vu Pugashetti, John S Kim, Swaraj Bose, et al.
Iscience|February 2, 2024
Cooperation between PRMT1 and PRMT6 drives lung cancer health disparities among Black/African American menPei-Ying Wu, Michelle Van Scoyk, Stephanie S McHale, et al.
Nature Communications|March 18, 2023
Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohortsAyodeji Adegunsoye, Chad A Newton, Justin M Oldham, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Molecular endotypes predict differential response to immunosuppressant therapy in non-IPF interstitial lung diseaseManoj V Maddali, Janelle V Pugashetti, Shaun M Pienkos, et al.
The Lancet. Respiratory Medicine|May 1, 2025
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validationAitana Alonso-González, David Jáspez, José M Lorenzo-Salazar, et al.
Pageof 10